The PROSPERO (Moher et al., 2014) database, indicating protocols for systematic reviews, has already been presented for HLA (CRD42021251670) (Deb et al., 2022), ACE2, and TMPRSS2 (CRD42021229963) contribution with COVID-19 outcomes. Here, ACE2 is linked to COVID-19.